Quantum Immunologics, Inc., a Major Mentor Capital Investee, Starts FDA-Authorized Breast Cancer Trials

SAN DIEGO--(BUSINESS WIRE)--Mentor Capital, Inc. (Pink Sheets:MNTR) announces that Quantum Immunologics, Inc. (QI) has met a significant milestone marking the beginning of its FDA-authorized breast cancer trial, the completion of the first clinical treatment injection.